1. Home
  2. ITRI vs ABCL Comparison

ITRI vs ABCL Comparison

Compare ITRI & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Itron Inc.

ITRI

Itron Inc.

N/A

Current Price

$97.20

Market Cap

4.1B

Sector

Industrials

ML Signal

N/A

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$9.68

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ITRI
ABCL
Founded
1977
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.1B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
ITRI
ABCL
Price
$97.20
$9.68
Analyst Decision
Buy
Strong Buy
Analyst Count
11
14
Target Price
★ $128.56
$18.69
AVG Volume (30 Days)
656.7K
★ 2.8M
Earning Date
10-27-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 25.48
10.91
EPS
★ 3.97
N/A
Revenue
★ $2,367,194,000.00
$75,128,000.00
Revenue This Year
$0.43
N/A
Revenue Next Year
$6.08
$13.74
P/E Ratio
$24.58
★ N/A
Revenue Growth
N/A
★ 160.56
52 Week Low
$77.77
$2.75
52 Week High
$108.20
$14.98

Technical Indicators

Market Signals
Indicator
ITRI
ABCL
Relative Strength Index (RSI) 54.25 33.61
Support Level $96.13 $3.45
Resistance Level $101.87 $12.91
Average True Range (ATR) 2.89 0.84
MACD -0.33 -0.22
Stochastic Oscillator 32.03 1.84

Price Performance

Historical Comparison
ITRI
ABCL

About ITRI Itron Inc.

Itron Inc provides solutions that measure, manage, and analyze energy and water use. The company offers grid edge intelligence, energy and water management, smart city applications, Industrial Internet of Things (IIoT), and critical infrastructure and related services. It operates under the Itron brand and has four reportable segments: Device Solutions, Networked Solutions, Resiliency Solutions, and Outcomes. Key revenue is generated from the Networked Solutions segment, which includes a combination of communicating endpoints (e.g., smart meters, modules, endpoints, and sensors), network infrastructure, network design services, and associated headend management and application software designed and sold as a complete solution for acquiring and transporting robust application-specific data.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: